JEN.DEJEN.DEXETRA
Loading
Year-over-year research & development expense growth
Percentile
P36
Within normal range
vs 3Y Ago
-7.9x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -3.34% |
| Q2 2025 | -7.59% |
| Q1 2025 | -9.65% |
| Q4 2024 | 23.00% |
| Q3 2024 | -7.37% |
| Q2 2024 | -2.08% |
| Q1 2024 | 2.81% |
| Q4 2023 | 0.28% |
| Q3 2023 | -1.34% |
| Q2 2023 | 11.37% |
| Q1 2023 | -12.28% |
| Q4 2022 | 22.61% |
| Q3 2022 | 0.42% |
| Q2 2022 | 6.20% |
| Q1 2022 | 46.73% |
| Q4 2021 | -15.78% |
| Q3 2021 | -10.16% |
| Q2 2021 | 21.71% |
| Q1 2021 | -23.18% |
| Q4 2020 | 22.74% |
| Q3 2020 | -12.29% |
| Q2 2020 | -0.92% |
| Q1 2020 | 16.66% |
| Q4 2019 | -2.33% |
| Q3 2019 | -18.98% |
| Q2 2019 | -4.06% |
| Q1 2019 | -1.50% |
| Q4 2018 | 8.13% |
| Q3 2018 | -0.09% |
| Q2 2018 | 6.10% |
| Q1 2018 | 8.60% |
| Q4 2017 | -4.44% |
| Q3 2017 | -7.22% |
| Q2 2017 | 9.17% |
| Q1 2017 | -10.59% |
| Q4 2016 | 18.56% |
| Q3 2016 | 1.25% |
| Q2 2016 | -7.30% |
| Q1 2016 | -2.02% |
| Q4 2015 | 11.12% |